Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).

NCT04187209 is registered in ClinicalTrials.gov with Wandercraft as lead sponsor.

NCT NCT04187209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04187209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).
Lead sponsor
Wandercraft
Phase
Not applicable
Overall status
Completed
Start date
September 11, 2019
Completion date
January 13, 2021
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

robotics, stroke, stroke, acute, stroke, subacute